Healthcare startup Leesol has received a CES 2025 Innovation Award in the Beauty & Personal Care category for its sleep management device Sleepisol Lite at the world’s largest consumer electronics and IT exhibition.
Leesol stated that the award recognizes both the technological innovation and ergonomic design of the product, and is expected to serve as an important milestone for the company’s expansion into the global healthcare market.
Sleepisol Lite utilizes neuromodulation technology to stimulate specific areas of the brain, helping improve sleep quality and enhance concentration. The core technology is Cranial Electrotherapy Stimulation (CES), which delivers subtle microcurrents to the brain.
By transmitting sleep-inducing frequencies, the device helps stimulate the production of sleep-related hormones such as serotonin, encouraging a more natural sleep cycle.
Clinical research conducted at Seoul National University Hospital showed promising results in improving insomnia symptoms. In a study involving 60 insomnia patients, the device not only improved sleep quality but also showed a 175% improvement in depression scale scores (BDI-II) compared to baseline. The research findings were published in the Journal of Sleep Research and the Journal of Affective Disorders.
Weighing just 33 grams, Sleepisol Lite features a lightweight design and a simple slide-button interface for easy operation. The device can operate for up to eight months without recharging, allowing users to use it continuously regardless of location.
Previously, Leesol introduced Sleepisol Original and Sleepisol Plus, both rechargeable models. The launch of Sleepisol Lite was aimed at removing the inconvenience of charging while also lowering the price barrier for consumers.
Leesol was founded by Dr. Seungwoo Lee, a former founder of the medical device venture Medison and currently head of research at Leesol, together with CEO Koo-sung Kwon, a patent attorney.
The company recently secured KRW 4 billion in Series A investment and was selected for the Deep Tech TIPS program by Korea’s Ministry of SMEs and Startups, enabling it to secure up to KRW 1.7 billion in additional R&D funding.
Source: Chosun Biz
https://www.chosun.com/economy/startup_story/2024/11/19/4HSQCQSMGVHNDBM7XAEUZMLGUQ/
Share:
Leesol Surpasses 50,000 Sales of “Sleepisol” and Launches 30-Day Trial Event to Celebrate Prime Minister’s Commendation
Leesol Selected as a “Baby Unicorn” in Korea’s 2025 Government Startup Program